Juanita L. Merchant | |
---|---|
Alma mater | |
Known for |
|
Scientific career | |
Fields |
|
Institutions |
Juanita L. Merchant is an American gastroenterologist and physiology researcher who has contributed to understanding of gastric response to chronic inflammation. [1] [2] She is currently the chief of the University of Arizona Division of Gastroenterology and Hepatology. [3] [4] Merchant was elected to the National Academy of Medicine in 2008, [5] and appointed an inaugural member of the NIH Council of Councils. [6]
Merchant grew up in Los Angeles. Her mother was an elementary school teacher. [7] She attended Stanford University, where she received her B.S. degree in biology. She went on to Yale University where she received both her M.D. and Ph.D. degrees in 1984. Merchant was the first African-American to earn a dual degree in medicine and cell biology from the Yale School of Medicine. [8] She completed her internal medicine residency and a research fellowship in gastroenterology at the Massachusetts General Hospital in Boston and her clinical fellowship in gastroenterology at UCLA. [9] Merchant is board certified by the American Board of Internal Medicine in both Internal Medicine (1987) and Gastroenterology (1993). [10]
After completing her clinical fellowship at UCLA in 1991, Merchant was recruited to the University of Michigan, where she was the H. Marvin Pollard Professor of Gastrointestinal Sciences in Internal Medicine in the Division of Gastroenterology and Molecular and Integrative Physiology. She additionally held a faculty appointment in the University of Michigan Cellular and Molecular Biology Graduate Program. [9] In 1994, Merchant was selected as an Howard Hughes Medical Institute (HHMI) Investigator; this appointment provided support for her research on gastrointestinal-tract cell growth and differentiation until 2002. [11] [12] In 2018, Merchant joined the faculty at the University of Arizona College of Medicine, where she is the chief of the UA Division of Gastroenterology and Hepatology as well as a professor of medicine in the UA Department of Medicine and a member of the Cancer Biology Research Program at the UA Cancer Center. [13] [14]
Merchant's research focuses on molecular mechanisms of gastric cancer biology, in particular the pathways involved in chronic inflammation processes. Since 1993, Merchant has been funded by NIDDK for a project on the "Transcriptional Control of Gastrin," which focuses on understanding the origin of gastrinomas. [15] In 2002, Merchant and collaborators found that antibiotics did a better job of treating gastritis in mice than blocking acid production with proton pump inhibitors. [16] Merchant holds a patent (granted in 2016) for a biomarker that can help diagnose Irritable Bowel Syndrome (IBS) and Crohn's Disease. [17] In 2018, Merchant was awarded additional NIH funding to study "MDSC Polarization and Helicobacter-Induced Gastric Metaplasia;" this grant will support the study of the role of the Sonic hedgehog (SHH) gene in gastric cancer. [18] Her research has led to authorship or co-authorship on over 100 research publications [19] and she has been the editor or co-editor of multiple books, such as the textbook Physiology of the Gastrointestinal Tract. [20]
Gastroenterology is the branch of medicine focused on the digestive system and its disorders. The digestive system consists of the gastrointestinal tract, sometimes referred to as the GI tract, which includes the esophagus, stomach, small intestine and large intestine as well as the accessory organs of digestion which include the pancreas, gallbladder, and liver.
Proton-pump inhibitors (PPIs) are a class of medications that cause a profound and prolonged reduction of stomach acid production. They do so by irreversibly inhibiting the stomach's H+/K+ ATPase proton pump.
Helicobacter pylori, previously known as Campylobacter pylori, is a gram-negative, flagellated, helical bacterium. Mutants can have a rod or curved rod shape, and these are less effective. Its helical body is thought to have evolved in order to penetrate the mucous lining of the stomach, helped by its flagella, and thereby establish infection. The bacterium was first identified as the causal agent of gastric ulcers in 1983 by the Australian doctors Barry Marshall and Robin Warren.
Basil Isaac Hirschowitz was an academic gastroenterologist from the University of Alabama at Birmingham (UAB) best known in the field for having invented an improved optical fiber which allowed the creation of a useful flexible endoscope. This invention revolutionized the practice of gastroenterology and also was a key invention in optical fiber communication in multiple industries.
The American Gastroenterological Association (AGA) is a medical association of gastroenterologists. Approximately 16,000 scientists and physicians are members of the organization.
Blood in stool or rectal bleeding looks different depending on how early it enters the digestive tract—and thus how much digestive action it has been exposed to—and how much there is. The term can refer either to melena, with a black appearance, typically originating from upper gastrointestinal bleeding; or to hematochezia, with a red color, typically originating from lower gastrointestinal bleeding. Evaluation of the blood found in stool depends on its characteristics, in terms of color, quantity and other features, which can point to its source, however, more serious conditions can present with a mixed picture, or with the form of bleeding that is found in another section of the tract. The term "blood in stool" is usually only used to describe visible blood, and not fecal occult blood, which is found only after physical examination and chemical laboratory testing.
This is a timeline of the events relating to the discovery that peptic ulcer disease and some cancers are caused by H. pylori. In 2005, Barry Marshall and Robin Warren were awarded the Nobel Prize in Physiology or Medicine for their discovery that peptic ulcer disease (PUD) was primarily caused by Helicobacter pylori, a bacterium with affinity for acidic environments, such as the stomach. As a result, PUD that is associated with H. pylori is currently treated with antibiotics used to eradicate the infection. For decades prior to their discovery, it was widely believed that PUD was caused by excess acid in the stomach. During this time, acid control was the primary method of treatment for PUD, to only partial success. Among other effects, it is now known that acid suppression alters the stomach milieu to make it less amenable to H. pylori infection.
Hashem B. El-Serag is a Palestinian-American physician and medical researcher best known for his research in liver cancer, hepatocellular carcinoma (HCC) and the hepatitis C virus. He serves as the Margaret M. and Albert B. Alkek Chairman of the Department of Medicine at Baylor College of Medicine as well as the Director of the Texas Medical Center Digestive Disease Center. El-Serag previously served as president of the American Gastroenterological Association and Editor-in-Chief of Clinical Gastroenterology and Hepatology.
Prof. Herbert Lochs, MD was a prominent German and Austrian medical doctor and scientist.
Blair S. Lewis, M.D., F.A.C.P., F.A.C.G., is an American board-certified gastroenterologist and Clinical Professor of Medicine at the Mount Sinai School of Medicine. Lewis is a specialist in the field of gastrointestinal endoscopy and was the primary investigator for the first clinical trial of capsule endoscopy for the small intestine and also the first clinical trial of capsule endoscopy for the colon.
Kurt Julius Isselbacher was a German-born American physician and held the position of Mallinckrodt Distinguished Professor of Medicine at Harvard Medical School and director emeritus of the Massachusetts General Hospital Cancer Center.
Sara Murray Jordan was an American gastroenterologist and former president of the American Gastroenterological Association. She practiced largely in Boston and specialized in peptic ulcer disease and gastric cancer.
Giovanni Gasbarrini is an Italian physician whose work in the field of internal medicine, hepatology and gastroenterology earned him the 2013 lifetime achievement award of the United European Gastroenterology (UEG) association.
Bruce F. Scharschmidt is an American physician-scientist whose career has spanned academic, business and non-profit sectors. He was a major contributor to the care of patients with liver disease and advancement of liver transplantation.
Pelayo Correa is a Colombian pathologist.
John Satterfield Fordtran is an emeritus professor of gastroenterology and past president of the American Society for Clinical Investigation.
Helicobacter heilmannii s.s. is a species within the Helicobacter genus of Gram negative bacteria. Helicobacter pylori is by far the best known Helicobacter species primarily because humans infected with it may develop gastrointestinal tract diseases such as stomach inflammation, stomach ulcers, duodenal ulcers, stomach cancers of the non-lymphoma type, and various subtypes of extranodal marginal zone lymphomass, e.g. those of the stomach, small intestines, large intestines, and rectumn. H. pylori is also associated with the development of bile duct cancer and has been associated with a wide range of other diseases although its role in the development of many of these other diseases requires further study. Humans infected with H. heilmannii s.s. may develop some of the same gastrointestinal diseases viz., stomach inflammation, stomach ulcers, duodenal ulcers, stomach cancers that are not lymphomas, and extranodal marginal B cell lymphomas of the stomach. Other non-H. pylori Helicobacter species that are known to be associated with these gastrointestinal diseases are Helicobacter bizzozeronii, Helicobacter suis, Helicobacter felis, and Helicobacter salomonis. Because of their disease associations, these four Helicobacter species plus H. heilmannii s.s. are often group together and termed Helicobacter heilmannii sensu lato.
Satish Sanku Chander Rao is the J.Harold Harrison Distinguished University Chair in Gastroenterology at the Medical College of Georgia, Augusta University. He served as the former President of the American Neurogastroenterology and Motility Society and as Chair of the American Gastroenterological Association (AGA) Institute Council, Neurogastroenterology/Motility Section.
Sharmila Anandasabapathy is a Sri Lankan-American physician and researcher in the field of gastrointestinal cancer. She is a professor of medicine in gastroenterology and serves as director of Baylor Global Health and vice president at the Baylor College of Medicine.
Pankaj "Jay" Pasricha is a physician and researcher specializing in gastroenterology and neurogastroenterology. He currently serves as the chair of medicine at the Mayo Clinic in Scottsdale, Arizona. Formerly, he served as the director of the Johns Hopkins Center for Neurogastroenterology and was the founder and co-director of the Amos Food, Body and Mind Center, Vice Chair of Medicine for Innovation and Commercialization in the Johns Hopkins School of Medicine, and Professor of Innovation Management at the Carey Business School.
{{cite book}}
: CS1 maint: location missing publisher (link) CS1 maint: others (link)